Congestive Heart Failure Drugs Market Size to Cross USD 13.5 Bn Revenue by 2031 | TMR Study
April 13, 2023 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The global congestive heart failure drugs market was valued at USD 6.7 Bn in 2022 and is estimated to reach USD 13.5 Bn by...
Eagle Pharmaceuticals Announces Submission of New Drug Application to U.S. Food and Drug Administration for Landiolol, a Beta-1 Adrenergic Blocker
June 01, 2022 06:50 ET
|
Eagle Pharmaceuticals, Inc.
-- Submission seeks approval for landiolol for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter -- --...
Franciosi Consulting Investigating Beta-Adrenergic Receptor Antagonists as Potential New Treatments for Essential Tremor
January 05, 2022 12:00 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Franciosi Consulting Ltd. will be performing structure activity analyses of published beta-adrenergic receptor antagonists (a.k.a. beta...